Division of Genetics and Genomic Medicine, Department of Pediatrics, University of California, Irvine, CA, USA.
Department of Medicine, Division of Hematology-Oncology, University of California, Irvine, CA, USA.
Mitochondrion. 2019 May;46:262-269. doi: 10.1016/j.mito.2018.07.006. Epub 2018 Aug 27.
Autosomal Dominant Optic Atrophy (ADOA) is a neuro-ophthalmic disease characterized by progressive bilateral vision loss, pallor of the optic disc, central vision loss, and impairment of color vision. Additionally, a small percentage of patients experience hearing loss and ataxia, while recent studies suggest disruption of cardiac and neuromuscular functions. In order to obtain a better understanding of the genotype-phenotype correlation of the various mutations in the optic atrophy 1 (OPA1) gene, we obtained both clinical and genetic information of ADOA patients from published reports. We conducted a systematic review of published OPA1 literature and identified 408 individuals with confirmed OPA1 mutations, 120 of whom reported extra-ocular (ADOA 'plus') manifestations through their descriptions of visual and multi-systemic symptoms. Our results show that there is a significant variation in frequency of the specific exons involved between the ADOA classic and ADOA 'plus' patients. Classic ADOA groups were more likely to have mutations in exon 8 and 9, while ADOA 'plus' groups were more likely to have mutations in exons 14, 15 and 17. Additional comparisons revealed significant differences between mutation types/domains and specific ADOA 'plus' manifestations. We also found that individuals with maternally inherited OPA1 mutations were significantly more likely to develop 'plus' manifestations than those with paternally inherited mutations. Overall, this study provides novel information regarding genotype-phenotype correlations of ADOA which warrants additional recommendations added to the current clinical management of ADOA patients.
常染色体显性视神经萎缩(ADOA)是一种神经眼科疾病,其特征是进行性双侧视力丧失、视盘苍白、中心视力丧失和色觉障碍。此外,一小部分患者会出现听力损失和共济失调,而最近的研究表明心脏和神经肌肉功能受到干扰。为了更好地了解视神经萎缩 1 (OPA1)基因突变的基因型-表型相关性,我们从已发表的报告中获得了 ADOA 患者的临床和遗传信息。我们对已发表的 OPA1 文献进行了系统综述,确定了 408 名经证实的 OPA1 突变患者,其中 120 名通过描述视觉和多系统症状报告了眼外(ADOA“+”)表现。我们的研究结果表明,经典 ADOA 组和 ADOA“+”组之间特定外显子受累的频率存在显著差异。经典 ADOA 组更有可能在外显子 8 和 9 中发生突变,而 ADOA“+”组更有可能在外显子 14、15 和 17 中发生突变。进一步的比较揭示了突变类型/结构域和特定 ADOA“+”表现之间的显著差异。我们还发现,与父系遗传 OPA1 突变相比,母系遗传 OPA1 突变的个体更有可能出现“+”表现。总的来说,这项研究为 ADOA 的基因型-表型相关性提供了新的信息,这需要对 ADOA 患者的当前临床管理增加额外的建议。